Dr Lalchandani Labs P/E Ratio
Current P/E Ratio
113.14
High Valuation
Very High - High growth expectations or significantly overvalued
Dr Lalchandani Labs (DLCL) P/E ratio is 113.14 (High), EPS (TTM) ₹0.07, current price ₹ on None — Very High - High growth expectations or significantly overvalued. See DLCL price book multiple to compare market price against book value per share.
Current Valuation Metrics
P/E Ratio
113.14
Current Price
₹
EPS (TTM)
₹0.07
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
111.34
Sector Median
40.64
Sector Rank
#11 of 57
Sector Percentile
19.3%
DLCL P/E Ratio — Valuation Signal & Historical Context
Dr Lalchandani Labs P/E 113.14 — signal: Overvalued. Read DLCL ex-dividend dates for the complete payout history and dividend yield track record.
- Stock appears overvalued with PE of 113.14, suggesting caution for new investments
DLCL vs Healthcare Services Peers — P/E Ratio Comparison
Dr Lalchandani Labs P/E 113.14 vs Healthcare Services average 111.34, median 40.64 — range 8.87–3045.0.
Sector Average
111.34
Sector Median
40.64
Lowest P/E
8.87
Highest P/E
3045.0
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.87 | ₹165 | Low |
| Abate AS Industries | ABATEAS | 12.29 | ₹153 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.5 | ₹18 | Low |
| Deccan Health Care | DECCAN | 12.92 | ₹31 | Low |
| Shanmuga Hospital | SHANMUGA | 14.28 | ₹59 | Low |
| Krsnaa Diagnostics | KRSNAA | 17.41 | ₹1,792 | Moderate |
| Sangani Hospitals | SANGANI | 17.61 | ₹59 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 17.64 | ₹1,178 | Moderate |
| Invicta Diagnostic | INVICTA | 17.85 | ₹85 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.9 | ₹1,088 | Moderate |